Dr. Whitney M. Rassbach, MD

Dr. Rassbach practices at Baychildren's Physicians in Castro Valley, California.

Dr. Rassbach's NPI, 1831352350, was assigned on July 3, 2008. Dr. Rassbach graduated from Vagelos College of Physicians and Surgeons in 2008. Dr. Rassbach holds California license A134888.

Dr. Rassbach's primary practice is Baychildren's Physicians, at 20055 Lake Chabot Rd, Castro Valley, CA 94546 in Alameda County. The practice phone is (415) 476-7220.

Dr. Rassbach's primary practice is Baychildren's Physicians in Castro Valley, California. Dr. Rassbach is also affiliated with Community Hospital of the Monterey Peninsula. The medical group on file is BayChildren's Medical Group. Dmand AI also links Dr. Rassbach to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rassbach practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Rassbach's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Rassbach is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Rassbach's licenses on file in 3 states: California, Michigan and New York.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives and upper respiratory infection (URI) among the conditions Dr. Rassbach treats.

CMS data shows 10,902 Medicare services from Dr. Rassbach across 14 procedure codes in 2024, for 415 Medicare patients. Medicare paid $135,651 for them. Every service was in an office.

CMS counts 415 Medicare patients who saw Dr. Rassbach in 2024. The largest group is 65 to 74, with 205 patients. 75% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rassbach's median patient age at 38, with 60% women.

In 2024, Dr. Rassbach wrote 1,436 Medicare Part D claims for 330 patients. 61% of them were for generic drugs. CMS names the drug for 1,249 of them, across 29 drugs with 11 or more claims each, at $578,673 in total drug cost. In 2023, CMS named 952 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Rassbach for performance year 2024, reported as part of a group. Dr. Rassbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Rassbach, published from 2014 to 2017. Dr. Rassbach has published most often in J Allergy Clin Immunol Pract. Dr. Rassbach's most frequent co-authors are Matthew Jason Greenhawt, MBA, MD, Joel H. Rubenstein, MD and Hugh Sampson, MD.

CMS Open Payments shows 2 general payments to Dr. Rassbach from 2 drug and device companies in 2017. Education make up the largest share, 63% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $18.

Dr. Rassbach graduated from Vagelos College of Physicians and Surgeons in 2008.

Dr. Rassbach is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.